Classification
Product TypeIngredient
Product FormBotanical extract (powder or oleoresin)
Industry PositionFood ingredient and therapeutic-goods ingredient
Market
In Australia, turmeric extract (curcumins) is relevant both as a permitted food colouring and as an ingredient used in complementary medicines. Market access is primarily import- and compliance-driven: importers must meet DAFF biosecurity requirements and (when imported for sale as food) comply with the Australia New Zealand Food Standards Code and DAFF’s Imported Food Inspection Scheme processes. If supplied as a therapeutic good (e.g., complementary medicine) or marketed with therapeutic indications, it must follow TGA requirements for ARTG entry pathways and GMP manufacturing expectations. The TGA has issued a safety alert noting rare liver injury associated with turmeric/curcumin-containing medicines and supplements, which increases compliance and pharmacovigilance sensitivity for this ingredient category.
Market RoleImport-dependent consumer and downstream formulation market (food colouring and complementary medicines)
Domestic RoleDownstream formulation/packaging and retail of complementary medicines; use as a natural colouring (curcumins/INS 100) in food manufacturing where applicable under the Food Standards Code
SeasonalityImport supply is typically available year-round; availability is driven more by international supply and compliance/inspection lead-times than by Australian seasonality.
Risks
Regulatory Compliance HighProduct classification and claims can be deal-breaking: if turmeric extract is supplied/marketed as a therapeutic good (e.g., complementary medicine) it must comply with TGA requirements (ARTG pathway rules, permissible ingredients/indications, sponsor obligations, and GMP). The TGA has also issued a safety alert for rare liver injury linked to turmeric/curcumin-containing medicines and supplements and has consulted on ingredient requirements, raising enforcement and change-management risk for non-compliant products.Decide and document intended regulatory pathway (food colouring/ingredient vs therapeutic good) before market entry; ensure label/claims and formulation align with the applicable regulator; monitor TGA updates for Curcuma/curcumin ingredient requirements and safety communications.
Food Safety MediumTurmeric supply chains have documented adulteration risk (e.g., lead chromate adulteration reported in upstream markets), which can translate into heavy-metal contamination concerns for imported turmeric-derived ingredients. For foods imported for sale, DAFF’s IFIS can hold consignments for inspection/testing and require corrective actions or re-export/disposal on failure.Require batch-level contaminant testing focused on heavy metals and authenticity/adulteration screening from suppliers; maintain lot traceability and retain samples; be prepared for IFIS inspection/testing workflows.
Documentation Gap MediumIncorrect import declarations or missing/unclear supporting documentation can place imported food consignments on hold until corrected, delaying release and increasing costs.Align product description, producer details, and lot code documentation across the Full Import Declaration and commercial documents; pre-audit documents against DAFF minimum documentary/import declaration requirements and BICON guidance.
Supply Chain Due Diligence LowLarge entities in the Australian market may have mandatory modern slavery reporting obligations, which can increase supplier onboarding and audit expectations for imported botanical ingredients.Map upstream suppliers and conduct risk screening; keep documented due diligence aligned to Modern Slavery Act reporting criteria where applicable.
Sustainability- Modern slavery risk screening and supply-chain transparency expectations for imported botanical ingredients (entity-threshold dependent under Australia’s Modern Slavery Act 2018).
Labor & Social- For entities meeting the reporting threshold, Modern Slavery Act statements require documenting actions to assess and address modern slavery risks in operations and supply chains; this can increase due diligence burden for imported botanical inputs.
Standards- GMP (for manufacture of complementary medicines supplied as therapeutic goods in Australia)
FAQ
If I sell a turmeric/curcumin product in Australia, is it regulated as a food or as a medicine?It depends on the product’s presentation and claims. If it is supplied as a therapeutic good (for example, a complementary medicine with therapeutic indications), TGA requirements apply (including ARTG pathway rules and GMP). If it is imported and sold as a food ingredient/colour, it must comply with the Australia New Zealand Food Standards Code and imported-food requirements administered by DAFF.
Are there any Australia-specific safety alerts for turmeric or curcumin products?Yes. The TGA published a safety alert advising that medicines and herbal supplements containing turmeric (Curcuma longa) and/or curcumin may cause liver injury in rare cases, and noted there are over 600 listed medicines in the ARTG that contain Curcuma species and/or curcumin.
Where are turmeric/curcumin medicines and supplements commonly sold in Australia?According to the TGA’s safety alert, turmeric/curcumin medicines and herbal supplements can be bought in supermarkets, health food shops and pharmacies.
What should an importer do first when bringing turmeric extract into Australia for sale as food?Start by checking DAFF’s BICON to confirm the product is permitted and to identify any biosecurity import conditions. For food imported for sale, be prepared to follow DAFF Imported Food Inspection Scheme processes (including lodgement of declarations/documents and possible inspection/testing) and ensure the product complies with the Australia New Zealand Food Standards Code.